Elevated Triglyceride Levels and Later Type 2 Diabetes

This study has been completed.
Sponsor:
Information provided by:
University of Tromso
ClinicalTrials.gov Identifier:
NCT01182935
First received: August 11, 2010
Last updated: July 19, 2011
Last verified: July 2011
  Purpose

Subjects with elevated serum triglycerides in the 4th Tromso study in 1994/1995 were re-examined with an oral glucose tolerance test to see predictive value of triglycerides regarding development of type 2 diabetes


Condition
Type 2 Diabetes

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Elevated Triglyceride Levels and Later Type 2 Diabetes

Resource links provided by NLM:


Further study details as provided by University of Tromso:

Primary Outcome Measures:
  • Number of subjects with type 2 diabetes diagnosed with oral glucose tolerance test (OGTT) [ Time Frame: At study enrollment in 2010 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The relation between serum 25(OH)D levels and blood glucose levels at OGTT [ Time Frame: At study enrollment in 2010 ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

serum


Enrollment: 3509
Study Start Date: April 2010
Study Completion Date: November 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
participants in the 4th Tromsø study

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

participants in the 4 Tromsø study 1994 and with elevated serum triglyceride levels

Criteria

Inclusion Criteria:

  • participants in the 4 Tromso study 1994 and with elevated serum triglyceride levels

Exclusion Criteria:

  • type 2 diabetes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01182935

Locations
Norway
Univesity of Tromsø
Tromsø, Norway, 9037
Sponsors and Collaborators
University of Tromso
Investigators
Principal Investigator: rolf jorde, md University of Tromso
  More Information

No publications provided

Responsible Party: Rolf Jorde, Univesity of Tromsø
ClinicalTrials.gov Identifier: NCT01182935     History of Changes
Other Study ID Numbers: UIT-ENDO-2010-3
Study First Received: August 11, 2010
Last Updated: July 19, 2011
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Keywords provided by University of Tromso:
vitamin D
triglycerides
type 2 diabetes

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Hypertriglyceridemia
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders

ClinicalTrials.gov processed this record on September 18, 2014